Report
Anna Baran
EUR 100.00 For Business Accounts Only

PRA Health's Bookings Growth Wanes and Data Solutions Strategy Remains Murky; Shares Overvalued

Narrow-moat PRA Health reported a mixed quarter, with currency headwinds and soft bookings growth. Total revenue of $722 million was below our expectations, representing 4% growth in constant currency (3% reported). Excluding reimbursed revenue, which was lighter than anticipated this quarter but is zero-margin and therefore does not impact earnings, total revenue was up 5% in constant currency, still below our expectations. We've reduced our projections for full-year revenue, and this adjustmen...
Underlying
PRA Health Sciences Inc.

PRA Health Sciences is a contract research organization engaged in providing outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries. The company has two reportable segments: Clinical Research, which performs a range of services across the spectrum of clinical development programs, from the filing of investigational new drug applications and similar regulatory applications to conducting all phases of clinical trials; and Data Solutions, which provides data, analytics, technology, and consulting solutions to the life sciences market including market intelligence services, consulting and services, and apps and technology.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Anna Baran

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch